Steegmann, J L
Baccarani, M
Clark, R E
Article History
First Online: 6 December 2016
Competing interests
: The authors declare the following relationships with pharmaceutical companies: Ariad—receipt of honoraria (JLS, MB) and research funding (JLS); Bristol-Myers-Squibb—receipt of honoraria (JLS, MB, REC), research funding (JLS, REC); Novartis—receipt of honoraria (JLS, MB, REC), research funding (JLS, REC); Pfizer—receipt of honoraria (JLS, MB, REC) and research funding (JLS, REC); Sanofi—receipt of honoraria (REC) and research funding (REC).